Synthesis and Biological Evaluation of Novel 2‐(Piperidin‐4‐yl)‐1,2,3,4‐tetrahydroisoquinoline and 2‐(Piperidin‐4‐yl)decahydroisoquinoline Antimycotics

Ähnliche Einträge

• Synthesis of novel benzylamine antimycotics and evaluation of their antimycotic potency
  von: Monika Klimt, et al.
  Veröffentlicht: (2024)
• A novel indole derivative, 2‐{3‐[1‐(benzylsulfonyl)piperidin‐4‐yl]‐2‐methyl‐1H‐indol‐1‐yl}‐1‐(pyrrolidin‐1‐yl)ethenone, suppresses hedgehog signaling and drug‐resistant tumor growth
  von: Joo Hyun Jung, et al.
  Veröffentlicht: (2024)
• Synthesis and photodynamic activity of new 5‐[(E)‐2‐(3‐alkoxy‐1‐phenyl‐1H‐pyrazol‐4‐yl)ethenyl]‐2‐phenyl‐3H‐indoles
  von: Gabrielė Varvuolytė, et al.
  Veröffentlicht: (2024)
• Development and Synthesis of Bioactive (3‐Arylediene‐1‐phenyl‐1 H ‐pyrazol‐4‐yl)acryloyl‐4‐hydroxy‐6‐methyl‐2 H ‐pyran‐2‐ones With Anti‐Malarial and Anti‐Inflammatory Activities
  von: Priyanka Rani, et al.
  Veröffentlicht: (2026)
• 4‐{3‐[(Pyridin‐4‐ylmethyl)amino]‐[1,2,4]triazolo[4,3‐b][1,2,4]triazin‐6‐yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator
  von: Zahra Zakeri Khatir, et al.
  Veröffentlicht: (2024)